Literature DB >> 3510581

Asbestos exposure--quantitative assessment of risk.

J M Hughes, H Weill.   

Abstract

Methods for deriving quantitative estimates of asbestos-associated health risks are reviewed and their numerous assumptions and uncertainties described. These methods involve extrapolation of risks observed at past relatively high asbestos concentration levels down to usually much lower concentration levels of interest today--in some cases, orders of magnitude lower. These models are used to calculate estimates of the potential risk to workers manufacturing asbestos products and to students enrolled in schools containing asbestos products. The potential risk to workers exposed for 40 yr to 0.5 fibers per milliliter (f/ml) of mixed asbestos fiber type (a permissible workplace exposure limit under consideration by the Occupational Safety and Health Administration (OSHA) ) are estimated as 82 lifetime excess cancers per 10,000 exposed. The risk to students exposed to an average asbestos concentration of 0.001 f/ml of mixed asbestos fiber types for an average enrollment period of 6 school years is estimated as 5 lifetime excess cancers per one million exposed. If the school exposure is to chrysotile asbestos only, then the estimated risk is 1.5 lifetime excess cancers per million. Risks from other causes are presented for comparison; e.g., annual rates (per million) of 10 deaths from high school football, 14 from bicycling (10-14 yr of age), 5 to 20 for whooping cough vaccination. Decisions concerning asbestos products require participation of all parties involved and should only be made after a scientifically defensible estimate of the associated risk has been obtained. In many cases to date, such decisions have been made without adequate consideration of the level of risk or the cost-effectiveness of attempts to lower the potential risk.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510581     DOI: 10.1164/arrd.1986.133.1.5

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  23 in total

1.  Extreme airborne asbestos concentrations in a public building.

Authors:  E Ganor; A Fischbein; S Brenner; P Froom
Journal:  Br J Ind Med       Date:  1992-07

2.  Low dose exposure to natural and man made fibres and the risk of cancer: towards a collaborative European epidemiology. Report of a workshop held in Paris , 10-12 June, 1991.

Authors:  A J Valleron; J Bignon; J M Hughes; T W Hesterberg; T Schneider; G J Burdett; P Brochard; D Hémon
Journal:  Br J Ind Med       Date:  1992-09

3.  Exposure and mineralogical correlates of pulmonary fibrosis in chrysotile asbestos workers.

Authors:  F H Green; R Harley; V Vallyathan; R Althouse; G Fick; J Dement; R Mitha; F Pooley
Journal:  Occup Environ Med       Date:  1997-08       Impact factor: 4.402

Review 4.  Dosimetry of inhaled elongate mineral particles in the respiratory tract: The impact of shape factor.

Authors:  Bahman Asgharian; T Price Owen; Eileen D Kuempel; Annie M Jarabek
Journal:  Toxicol Appl Pharmacol       Date:  2018-05-05       Impact factor: 4.219

5.  Carcinogenicity of chrysotile asbestos: a case control study of textile workers.

Authors:  J M Dement
Journal:  Cell Biol Toxicol       Date:  1991-01       Impact factor: 6.691

6.  Cancer mortality in relation to measures of occupational exposure to crocidolite at Wittenoom Gorge in Western Australia.

Authors:  N H de Klerk; B K Armstrong; A W Musk; M S Hobbs
Journal:  Br J Ind Med       Date:  1989-08

7.  Mortality and cancer incidence in chloralkali workers exposed to inorganic mercury.

Authors:  L Barregård; G Sällsten; B Järvholm
Journal:  Br J Ind Med       Date:  1990-02

8.  Future trends in mortality of French men from mesothelioma.

Authors:  A Banaei; B Auvert; M Goldberg; A Gueguen; D Luce; S Goldberg
Journal:  Occup Environ Med       Date:  2000-07       Impact factor: 4.402

9.  Asbestos: promotion or prohibition?

Authors:  W K Morgan
Journal:  CMAJ       Date:  1987-03-15       Impact factor: 8.262

10.  Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma.

Authors:  A Baldi; D Santini; F Vasaturo; M Santini; G Vicidomini; M Pia Di Marino; V Esposito; A M Groeger; G Liuzzi; B Vincenzi; G Tonini; M Piccoli; F Baldi; S Scarpa
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.